Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
Submitted by
admin
on February 26, 2016 - 9:34am
Source:
BioPharma Dive
News Tags:
Eli Lilly
Portrazza
Europe
biologics
non-small cell lung cancer
Headline:
Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
Do Not Allow Advertisers to Use My Personal information
